Company intelligence / Profile preview

Janus Henderson

London, England, United Kingdomjanushenderson.com ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Janus Henderson is a global asset management group headquartered in London. While it manages several funds focused on biotechnology and healthcare equities—such as the Biotech Innovation Fund and Global Life Sciences Fund—it does not itself develop drugs or therapeutic platforms. Its biotech-focused investment products have outperformed sector benchmarks in recent years[3][4][7].

Industry: Investors

Drug pipeline

4 assets

farxiga

Commercial

Indications: Diabetes, Heart disease, Kidney disease

3 more assets in the full pipeline.

Request access →

Partnerships

Joint venture with Privacore Capital for alternative assets

Beyond the preview

Go deeper on Janus Henderson.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Janus Henderson.

Explore the full profile